These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14531407)

  • 21. N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population.
    Solbu MD; Toft I; Løchen ML; Mathiesen EB; Eriksen BO; Melsom T; Njølstad I; Wilsgaard T; Jenssen TG
    J Am Soc Nephrol; 2016 Feb; 27(2):533-42. PubMed ID: 26047791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between insurance status and mortality in individuals with albuminuria: an observational cohort study.
    Saunders MR; Ricardo AC; Chen J; Chin MH; Lash JP
    BMC Nephrol; 2016 Mar; 17():27. PubMed ID: 26960447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
    Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.
    Verhave JC; Gansevoort RT; Hillege HL; Bakker SJ; De Zeeuw D; de Jong PE;
    Kidney Int Suppl; 2004 Nov; (92):S18-21. PubMed ID: 15485409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based association between urinary excretion of sodium, potassium and its ratio with albuminuria in Chinese.
    Yan L; Guo X; Wang H; Zhang J; Tang J; Lu Z; Cai X; Liu L; Gracely EJ; Ma J
    Asia Pac J Clin Nutr; 2016 Dec; 25(4):785-797. PubMed ID: 27702722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea.
    Seo MH; Lee JY; Ryu S; Won YS; Sung KC
    Am J Hypertens; 2017 Aug; 30(8):799-807. PubMed ID: 28472229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study.
    Hermans MM; Henry R; Dekker JM; Kooman JP; Kostense PJ; Nijpels G; Heine RJ; Stehouwer CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1942-52. PubMed ID: 17460143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.
    Oterdoom LH; Gansevoort RT; Schouten JP; de Jong PE; Gans RO; Bakker SJ
    Atherosclerosis; 2009 Dec; 207(2):534-40. PubMed ID: 19535078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kidney, a cardiovascular risk marker, and a new target for therapy.
    de Zeeuw D; Hillege HL; de Jong PE
    Kidney Int Suppl; 2005 Sep; (98):S25-9. PubMed ID: 16108967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-grade albuminuria and cardiovascular risk : what is the evidence?
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Paar WD; Bramlage P; Pittrow D; Böhm M
    Clin Res Cardiol; 2007 May; 96(5):247-57. PubMed ID: 17453140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?
    de Zeeuw D
    Kidney Int Suppl; 2004 Nov; (92):S2-6. PubMed ID: 15485410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
    Åkerblom A; Clare RM; Lokhnygina Y; Wallentin L; Held C; Van de Werf F; Moliterno DJ; Patel UD; Leonardi S; Armstrong PW; Harrington RA; White HD; Aylward PE; Mahaffey KW; Tricoci P
    Am Heart J; 2016 Aug; 178():1-8. PubMed ID: 27502846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24).
    Drion I; van Hateren KJ; Joosten H; Alkhalaf A; Groenier KH; Kleefstra N; Wetzels JF; Bilo HJ
    Age Ageing; 2012 May; 41(3):345-50. PubMed ID: 22314695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons.
    Jørgensen L; Jenssen T; Heuch I; Jacobsen BK
    J Intern Med; 2008 Nov; 264(5):493-501. PubMed ID: 18624904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
    van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey A; de Jong P; Gansevoort RT; ; van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey AS; de Jong PE; Gansevoort RT; Levey A; El-Nahas M; Eckardt KU; Kasiske BL; Ninomiya T; Chalmers J; Macmahon S; Tonelli M; Hemmelgarn B; Sacks F; Curhan G; Collins AJ; Li S; Chen SC; Hawaii Cohort KP; Lee BJ; Ishani A; Neaton J; Svendsen K; Mann JF; Yusuf S; Teo KK; Gao P; Nelson RG; Knowler WC; Bilo HJ; Joosten H; Kleefstra N; Groenier KH; Auguste P; Veldhuis K; Wang Y; Camarata L; Thomas B; Manley T
    Kidney Int; 2011 Jun; 79(12):1341-52. PubMed ID: 21307840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.